These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7822099)

  • 21. Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).
    Pang YP; Cusack B; Groshan K; Richelson E
    J Biol Chem; 1996 Jun; 271(25):15060-8. PubMed ID: 8663052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potencies of various neurotensin-(8-13) analogs for inhibition of heat-induced edema in the anesthetized rat.
    Gao GC; Wei ET
    Regul Pept; 1995 Mar; 56(1):41-8. PubMed ID: 7770632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.
    Seebach D; Lukaszuk A; Patora-Komisarska K; Podwysocka D; Gardiner J; Ebert MO; Reubi JC; Cescato R; Waser B; Gmeiner P; Hübner H; Rougeot C
    Chem Biodivers; 2011 May; 8(5):711-39. PubMed ID: 21560227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification in the rat neurotensin receptor of amino-acid residues critical for the binding of neurotensin.
    Botto JM; Chabry J; Nouel D; Paquet M; Séguéla P; Vincent JP; Beaudet A; Mazella J
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):311-7. PubMed ID: 9191107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radioactive analogs of neurotensin. II. Preparation of tritiated neurotensin from a synthetic multi-unsaturated derivative].
    Labbé-Jullié C; Blanot D; Morgat JL; Kitabgi P; Checler F; Vincent JP; Granier C; Van Rietschoten J
    Biochimie; 1983 Oct; 65(10):553-62. PubMed ID: 6317062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiolabeled ligands specific for the G protein-coupled state of neurotensin receptors.
    Gaudriault G; Zsürger N; Vincent JP
    J Neurochem; 1996 Dec; 67(6):2590-8. PubMed ID: 8931494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.
    Einsiedel J; Hübner H; Hervet M; Härterich S; Koschatzky S; Gmeiner P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2013-8. PubMed ID: 18276136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR solution structure of neurotensin in membrane-mimetic environments: molecular basis for neurotensin receptor recognition.
    Coutant J; Curmi PA; Toma F; Monti JP
    Biochemistry; 2007 May; 46(19):5656-63. PubMed ID: 17441729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies of neurotensin, several fragments and analogous in the isolated perfused rat heart.
    Quirion R; Rioux F; Regoli D; St-Pierre S
    Eur J Pharmacol; 1980 Sep; 66(4):257-66. PubMed ID: 7418719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties.
    Maes V; Garcia-Garayoa E; Bläuenstein P; Tourwé D
    J Med Chem; 2006 Mar; 49(5):1833-6. PubMed ID: 16509599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons.
    Checler F; Mazella J; Kitabgi P; Vincent JP
    J Neurochem; 1986 Dec; 47(6):1742-8. PubMed ID: 3021902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
    Checler F; Vincent JP; Kitabgi P
    J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity studies with neurotensin: analysis of positions 9, 10 and 11.
    Quirion R; Regoli D; Rioux F; St-Pierre S
    Br J Pharmacol; 1980 Aug; 69(4):689-92. PubMed ID: 7437646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
    Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
    J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier.
    Kokko KP; Hadden MK; Price KL; Orwig KS; See RE; Dix TA
    Neuropharmacology; 2005 Mar; 48(3):417-25. PubMed ID: 15721174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation, primary structure, and effects on alpha-melanocyte-stimulating hormone release of frog neurotensin.
    Desrues L; Tonon MC; Leprince J; Vaudry H; Conlon JM
    Endocrinology; 1998 Oct; 139(10):4140-6. PubMed ID: 9751493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
    Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.
    Fanelli R; Besserer-Offroy É; René A; Côté J; Tétreault P; Collerette-Tremblay J; Longpré JM; Leduc R; Martinez J; Sarret P; Cavelier F
    J Med Chem; 2015 Oct; 58(19):7785-95. PubMed ID: 26348111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.